A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)
Trial details
- Registry ID
- NCT04849741
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as ION373
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)NCT04849741 | IONS | Phase 3 | Active not recruiting | 2025-08-22Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |